載入...
Clinical potential of midostaurin in advanced systemic mastocytosis
Advanced (Ad) systemic mastocytoses (SM) include aggressive SM (ASM) and mast cell leukemia (MCL) with or without an associated clonal hematological non-mast cell lineage disease (AHNMD). They are rare (<15%) but are associated with a poor prognosis due to rapid organ dysfunction. To date, respon...
Na minha lista:
| 發表在: | Blood Lymphat Cancer |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6467340/ https://ncbi.nlm.nih.gov/pubmed/31360083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S87186 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|